Published in Pharma Law Weekly, December 2nd, 2008
"The findings showed hypoperfusion and no vasoreactivity in the territory of the left middle cerebral artery. During follow-up he...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2008-12-02)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.